News and Trends 10 Nov 2022
Promising drug candidate discovered for prevention of type 1 diabetes
According to a new study in Finland, type 1 diabetes could be prevented by inhibiting a gene associated with the…
Diabetes
- Latest Posts
More News! 10 Nov 2022
Eye disease therapies being developed after Breye Therapeutics’ €4M seed financing
Breye Therapeutics ApS a biopharmaceutical company developing therapies for retinal vascular diseases today (November 10) has closed a seed financing…
News and Trends 4 Nov 2022
Creative Medical Technology Holdings announces FDA clearance of diabetes drug
Creative Medical Technology Holdings yesterday (November 3) announced its investigational new drug (IND) application has been cleared by the U.S.…
News and Trends 3 Nov 2022
New method to treat diabetic foot ulcers revealed by Biocomposites Ltd
Diabetic foot infection costs the UK’s NHS around £900 million ($990 million) a year, bringing severe misery to patients. Usually,…
ADVERTISEMENT
News and Trends 1 Nov 2022
Tetris Pharma launches hypoglycemia injector pen in Germany
Tetris Pharma Ltd, a subsidiary of biopharma company Arecor Therapeutics plc, has launched Ogluo (glucagon prefilled autoinjector pen) in Germany…
News and Trends 19 Oct 2022
CDF15 cytokine a promising therapeutic target against type 2 diabetes
CDF15 cytokine a promising therapeutic target against type 2 diabetes Researchers have conducted a review study on growth differentiation factor…
Best in Biotech 7 Oct 2022
Needle-free diabetes care: 7 devices that painlessly monitor blood sugar
Will the daily routine of finger pricking to monitor blood sugar levels finally come to an end for the millions…
News and Trends 30 Sep 2022
Beyond Biotech podcast 16: Adocia, Omnio, Phenomix Sciences, Tridek-One
This week, we have four guests: Olivier Soula, deputy-CEO and director of R&D at Adocia; Ulrika Norin, CEO of Omnio;…
News and Trends 28 Sep 2022
Ilya Pharma enrols first patient in diabetic foot ulcer study
Ilya Pharma AB says the first patients have been enrolled in a phase II study for its lead candidate ILP100-Topical…
News and Trends 22 Sep 2022
New phase 1 biomarker results reported by Glyscend Therapeutics for diabetes drug
A U.S.-based biotech yesterday (September 21) reported additional biomarker results for a treatment of type 2 diabetes (T2D) from a…
ADVERTISEMENT
News and Trends 20 Sep 2022
Positive results from Arecor Therapeutics’ clinical trial of rapid, concentrated insulin
Arecor Therapeutics today (September 20) announced positive results from a phase 1 clinical trial of its rapid, concentrated insulin product.…
News and Trends 19 Sep 2022
CellResearch Corporation announces positive results of phase I diabetic foot ulcer study
CellResearch Corporation, a Singapore-based biopharma company says it has successfully closed the first phase I study for CorLiCyte, a stem…
More News! 16 Sep 2022
Strategic collaboration for drug to treat NASH, obesity and diabetes announced
A conditional and exclusive license agreement to develop and commercialize a drug to treat nonalcoholic steatohepatitis (NASH), obesity and type…
News and Trends 7 Sep 2022
Adocia takes steps with implants for treatment of type 1 diabetes
French biopharma company Adocia has established a first proof of concept for its AdoShell Islets implant by achieving glycemic control…
News and Trends 1 Sep 2022
Provention Bio looks to advance diabetes drug through $125M loan
U.S. biopharma company Provention Bio, Inc. has secured a term loan facility of up to $125 million with Hercules Capital,…
Opinion 1 Sep 2022
The evolution of diabetes management
Diabetes management has progressed leaps and bounds in the last 100 years. Francine Kaufman, Chief Medical Officer of Senseonics, outlines…
ADVERTISEMENT
News and Trends 2 Aug 2022
Enrollment completed for trial looking at treatment of diabetic kidney disease
Enrollment has been completed for a study of a regenerative cell therapy investigational product for intra-renal artery administration to treat…
News and Trends 2 Aug 2022
COUR NanoParticle technology halts Type 1 diabetes progression
COUR Pharmaceuticals has published details of a study with the Miller Lab at Northwestern University, looking at type 1 diabetes.…
News and Trends 1 Aug 2022
Arecor Therapeutics adds diabetes product to portfolio after significant acquisition
Arecor Therapeutics plc has bought all of Tetris Pharma Ltd shares adding a key commercial diabetes product to its portfolio.…
News and Trends 7 Jul 2022
Treatments set to improve for lethal lung disease and ulcers following drug synergy data revelation
New data has been published today (July 7) evidencing findings that could lead to better treatment for people with lethal…